15-Lipoxygenase Inhibitor 1 is primarily used in research to study the role of 15-lipoxygenase enzymes in various biological processes, including inflammation, oxidative stress, and metabolic disorders. It is applied in investigating inflammatory diseases such as asthma, rheumatoid arthritis, and other respiratory conditions, as 15-lipoxygenase is involved in the production of pro-inflammatory mediators. This inhibitor helps in understanding the pathways of atherosclerosis and cardiovascular diseases, as the enzyme contributes to the oxidation of low-density lipoprotein (LDL), a key factor in plaque formation. Additionally, it is utilized in cancer research to explore the enzyme's role in tumor progression and cell signaling. The compound is also valuable in studying neurological disorders like Alzheimer's and Parkinson's disease, where links between inflammation, oxidative stress, and neurodegeneration are implicated. Overall, it serves as a tool to dissect the enzyme's function, support drug development, and develop potential therapeutic strategies with improved specificity and reduced side effects.